Dr. Tarek Elrafei, DO
- Medicare services, 2024
- 50,728
- Medicare patients, 2024
- 378
- Part D claims, 2024
- 2,057
- Publications
- 16
- Hospital affiliations
- 2
- Practice address
- 2330 Eastchester Rd, Bronx, NY 10469-5930
- Practice phone
- Call (631) 751-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Port Jefferson Station Medical Oncology
Multi-specialty group site · Bronx, New York
Find Dr. Elrafei's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tarek Elrafei is a hematologist and oncologist in Bronx, New York
Dr. Elrafei practices at Port Jefferson Station Medical Oncology in Bronx, New York.
Dr. Elrafei's NPI, 1467563296, was assigned on August 31, 2006. Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995. Dr. Elrafei holds New York license 212011.
- NPI
- 1467563296NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0446142855
- NPI enumeration date
- August 31, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (631) 751-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tarek Elrafei practices at Port Jefferson Station Medical Oncology in Bronx, New York
Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology, at 2330 Eastchester Rd, Bronx, NY 10469-5930. The practice phone is (631) 751-3000.
- Port Jefferson Station Medical Oncology2330 Eastchester Rd, Bronx, NY 10469-5930Phone(631) 751-3000
Source: Dmand AI Affiliation Data
Dr. Tarek Elrafei is affiliated with 4 sites of care and 2 medical groups
Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology in Bronx, New York. Dr. Elrafei is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Harlem Medical Associates. Dmand AI also links Dr. Elrafei to 1 more hospital, 1 physician office and 1 medical group, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Tarek Elrafei's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elrafei practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Port Jefferson Station Medical Oncology | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tarek Elrafei is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Elrafei's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Elrafei is board certified in hematology by the American Board of Internal Medicine. Dr. Elrafei is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Clinical focus
Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Elrafei treats.
Hematologists and oncologists near Dr. Elrafei
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tarek Elrafei billed Medicare for 50,728 services in 2024
CMS data shows 50,728 Medicare services from Dr. Elrafei across 60 procedure codes in 2024, for 378 Medicare patients. Medicare paid $292,534 for them.
Dr. Elrafei's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 16,4952024: 38,809135%
- Lab and pathology
- 2023: 9,7592024: 9,3734%
- Office and hospital visits
- 2023: 1,3292024: 1,15913%
- Surgery
- 2023: 9322024: 9795%
- Tests and treatments
- 2023: 4552024: 40810%
- Other services
- 2023: 122024: 0100%
Where Dr. Elrafei's Medicare services took place, 2024
- In an office50,672100%
- In a facility560%
Dr. Elrafei compared with the New York median for hematologists and oncologists, 2024
- Dr. Elrafei
- New York median
- Medicare services
- 50,728vs 66875.9 times
- Medicare patients
- 378vs 21080% above
- Part D claims
- 1,684vs 2586.5 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Elrafei's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Elrafei?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Elrafei and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Tarek Elrafei treated 378 Medicare patients in 2024, average age 75
CMS counts 378 Medicare patients who saw Dr. Elrafei in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Elrafei's median patient age at 59, with 66% women.
Dr. Elrafei's Medicare patients by age, 2024
Dr. Elrafei's Medicare patients by sex, 2024
- Women23061%
- Men14839%
Chronic conditions among Dr. Elrafei's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Diabetes52%
- Arthritis46%
- Cancer41%
- Chronic kidney disease40%
- Ischemic heart disease32%
- COPD23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Elrafei's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 59
Patient panel by sex, all payers
- Women66%
- Men31%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Tarek Elrafei wrote 2,057 Medicare Part D claims in 2024
In 2024, Dr. Elrafei wrote 2,057 Medicare Part D claims for 253 patients. CMS names the drug for 1,684 of them, across 56 drugs with 11 or more claims each, at $8,390,306 in total drug cost. In 2023, CMS named 1,135 claims across 41 drugs.
Dr. Elrafei's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Elrafei's Part D claims, 2024
- Opioids2%49 of 2,057 claims
- Antibiotics2%44 of 2,057 claims
- Antipsychotics, patients 65 and over1%11 of 2,057 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1352024: 1,68448%
Drugs named by CMS: 56 in 2024, 41 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Tarek Elrafei offers telehealth to Medicare patients
Dr. Elrafei accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elrafei as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tarek Elrafei has 16 publications on record
Dmand AI links 16 papers to Dr. Elrafei, published from 2014 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Bone Marrow, Bone Marrow Examination and Ilium. Dr. Elrafei's most frequent co-authors are Marianna Strakhan, MD, Karenza Michelle Alexis, MD and Shirin Attarian, MD.
Dr. Elrafei's papers by year, 2014 to 2024
Topics Dr. Elrafei writes about most
- Bone Marrow
- Bone Marrow Examination
- Ilium
Dr. Elrafei's most frequent co-authors
- Marianna Strakhan, MD5 shared papers
- Karenza Michelle Alexis, MD3 shared papers
- Shirin Attarian, MD2 shared papers
Recent publications by Dr. Elrafei
See who Dr. Elrafei researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Elrafei works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tarek Elrafei received $2,141 in industry payments from 2016 to 2025
CMS Open Payments shows 91 general payments to Dr. Elrafei from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Novartis Pharmaceuticals Corporation paid the most, $818.
General payments to Dr. Elrafei by program year, 2016 to 2025
General payments to Dr. Elrafei by kind, 2016 to 2025
- Food and beverage$1,04349%
- Travel and lodging$81838%
- Education$28013%
Companies that paid Dr. Elrafei the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Tarek Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine
Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
- Board certified in 2000 - 2025
- Board certified in 1998 - 2026
Source: Dmand AI Professional Profile Data
Dr. Tarek Elrafei accepts plans from 20 insurance carriers
Dr. Elrafei is in network with 20 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Elevance
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- Cigna
- +12 more carriersWith a free account
Plan types Dr. Elrafei accepts, by number of carriers
- PPO12
- Medicare10
- HMO8
- EPO5
- Medicaid3
- POS3
Source: Dmand AI Insurance Network Data
Sources for Dr. Tarek Elrafei's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tarek Elrafei
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tarek Elrafei's NPI number?
Dr. Tarek Elrafei's NPI number is 1467563296. It was assigned on August 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Tarek Elrafei?
Dr. Tarek Elrafei is a hematologist and oncologist in Bronx, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Tarek Elrafei practice?
Dr. Elrafei practices at 2330 Eastchester Rd, Bronx, NY 10469-5930. Dr. Elrafei's primary practice is Port Jefferson Station Medical Oncology in Bronx, New York. Dmand AI also links Dr. Elrafei to 1 hospital, 1 physician office and 1 medical group.
What is Dr. Tarek Elrafei's office phone number?
The practice phone on file for Dr. Elrafei is (631) 751-3000.
What is Dr. Tarek Elrafei's medical license number?
Dr. Elrafei holds New York license 212011.
Which hospitals is Dr. Tarek Elrafei affiliated with?
Dr. Elrafei is affiliated with Montefiore Einstein Hospital-Moses Campus. Dmand AI links Dr. Elrafei to 1 more hospital.
What medical group is Dr. Tarek Elrafei part of?
Dr. Elrafei is linked to Harlem Medical Associates. Dmand AI links Dr. Elrafei to 1 more medical group.
Does Dr. Tarek Elrafei accept Medicare?
Yes. CMS data shows Dr. Elrafei billed Medicare for 50,728 services in 2024, and Dr. Elrafei accepts Medicare assignment.
Does Dr. Tarek Elrafei offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Elrafei as offering telehealth services.
How many Medicare patients does Dr. Tarek Elrafei see?
CMS counts 378 Medicare patients who saw Dr. Elrafei in 2024, with an average age of 75.
Show 9 more questionsShow fewer questions
Is Dr. Tarek Elrafei board certified?
Yes. Dr. Elrafei is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Tarek Elrafei bill to Medicare?
In 2024, Dr. Elrafei's most billed Medicare services were injected or infused drug (J1439), lab and pathology test (88185) and surgery: heart and blood vessels (36415).
Where did Dr. Tarek Elrafei go to medical school?
Dr. Elrafei graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1995.
What drugs does Dr. Tarek Elrafei prescribe most?
In 2024 Medicare Part D data, Dr. Elrafei's most prescribed drugs by claims were Aranesp, Procrit and Akynzeo.
Has Dr. Tarek Elrafei received payments from drug or device companies?
CMS Open Payments shows $2,141 in general payments to Dr. Elrafei from 20 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Tarek Elrafei been practicing?
Dr. Elrafei graduated from medical school in 1995, 31 years ago.
Does Dr. Tarek Elrafei do research?
Dmand AI links 16 publications to Dr. Elrafei, published from 2014 to 2024.
Who does Dr. Tarek Elrafei publish with?
Dr. Elrafei's most frequent co-authors are Marianna Strakhan, MD (5 shared papers), Karenza Michelle Alexis, MD (3 shared papers) and Shirin Attarian, MD (2 shared papers).
What insurance does Dr. Tarek Elrafei accept?
Dr. Elrafei is in network with 20 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card